0002026298-24-000003.txt : 20240610 0002026298-24-000003.hdr.sgml : 20240610 20240607182714 ACCESSION NUMBER: 0002026298-24-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240610 DATE AS OF CHANGE: 20240607 EFFECTIVENESS DATE: 20240610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurawell Therapeutics, Inc. CENTRAL INDEX KEY: 0002026298 ORGANIZATION NAME: IRS NUMBER: 844729159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-515484 FILM NUMBER: 241031044 BUSINESS ADDRESS: STREET 1: 18501 COLLINS AVE, #4301 CITY: SUNNY ISLES BEACH STATE: FL ZIP: 33160 BUSINESS PHONE: 703-472-8714 MAIL ADDRESS: STREET 1: 18501 COLLINS AVE, #4301 CITY: SUNNY ISLES BEACH STATE: FL ZIP: 33160 D 1 primary_doc.xml X0708 D LIVE 0002026298 Neurawell Therapeutics, Inc. 18501 COLLINS AVE, #4301 SUNNY ISLES BEACH FL FLORIDA 33160 703-472-8714 DELAWARE None None Corporation true Magid Abraham c/o Neurawell Therapeutics, Inc. 18501 Collins Ave, #4301 Sunny Isles Beach FL FLORIDA 33160 Executive Officer Director Tom Insel c/o Neurawell Therapeutics, Inc. 18501 Collins Ave, #4301 Sunny Isles Beach FL FLORIDA 33160 Executive Officer Director Jack Abraham c/o Neurawell Therapeutics, Inc. 18501 Collins Ave, #4301 Sunny Isles Beach FL FLORIDA 33160 Director Other Technology Decline to Disclose 06b false 2024-05-20 false true false 0 3000000 1619999 1380001 false 4 0 0 0 false Neurawell Therapeutics, Inc. /s/ Magid Abraham Magid Abraham Chief Executive Officer 2024-06-07